Skip to main content
. 2012 Oct 10;7(10):e46956. doi: 10.1371/journal.pone.0046956

Figure 2. Inhibitory effect of CM-hAMTC and CM-hAM in presence of neutralizing antibodies.

Figure 2

Lymphocyte proliferation, stimulated with anti-CD3 (PBMC + αCD3), in presence of 100 μl of control medium or CM with (white bars) or without (black bars) the addition of neutralizing antibodies against IL-10 (A), TGF-β (B), HGF (C), IL-6 (D), mix of antibodies anti-IL-10, -TGF-β, -HGF and -IL-6 (E). Data represent the mean and SD of at least four independent experiments. * = p<0.05, ** = p<0.01 versus PBMC + αCD3.